Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions

The American Journal of Cardiology
Young Joon HongRon Waksman

Abstract

We sought to determine the outcome with undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions. Using intravascular ultrasound guidance, 209 saphenous vein graft lesions were treated with drug-eluting stents (153 sirolimus-eluting and 56 paclitaxel-eluting stents). The lesions were divided into 3 groups according to the ratio of the stent diameter to the average intravascular ultrasound reference lumen diameter: group I, <0.89; group II, 0.9 to 1.0; and group III, >1.0. Angiographic no-reflow was defined as a Thrombolysis In Myocardial Infarction flow grade of 0, 1, and 2 after percutaneous coronary intervention. Plaque intrusion was defined as tissue extrusion through the stent struts. Stent malapposition was defined as one or more stent struts that had clearly separated from the vessel wall with evidence of blood speckles behind the strut. No significant differences were found in the use of distal protection devices (group I, 44%; group II, 35%; and group III, 36%; p = 0.5); and no significant differences were found in the incidence of stent malapposition among the 3 groups (group I, 21%; group II, 42%; and group III, 52%; p = 0.001). The plaque intrusion area (group I, 0.13 +/- ...Continue Reading

References

Apr 15, 1995·The American Journal of Cardiology·K M AbboR D Safian
Sep 1, 1994·Catheterization and Cardiovascular Diagnosis·E GronenschildF Tijdens
Jun 1, 1993·Journal of the American College of Cardiology·P J de FeyterP W Serruys
Sep 1, 1996·Catheterization and Cardiovascular Diagnosis·D S Baim, J P Carrozza
Nov 3, 1998·Circulation·S EleziA Schömig
Apr 15, 2004·The American Journal of Cardiology·Ioannis IakovouJeffrey W Moses

❮ Previous
Next ❯

Citations

May 10, 2011·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Kohei WakabayashiRon Waksman
Dec 14, 2011·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Omar M JeroudiEmmanouil S Brilakis
Mar 20, 2014·Current Treatment Options in Cardiovascular Medicine·Emmanouil S BrilakisSubhash Banerjee
Jul 9, 2010·The American Journal of Cardiology·Armando Perez De PradoFelipe Fernandez-Vazquez
May 4, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Arif MahmoodEmmanouil S Brilakis
Jul 29, 2010·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Lowell F Satler
Feb 18, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Gabriel MaluendaAugusto D Pichard
Jun 18, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Emmanouil S Brilakis, Subhash Banerjee
Jun 18, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Jorge A Belardi, Mariano Albertal
Jul 29, 2010·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Neeraj BadheyEmmanouil S Brilakis
May 11, 2016·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Sakura NagumoHiroshi Suzuki
Aug 20, 2011·JACC. Cardiovascular Interventions·Michael S LeeGregg W Stone
Nov 26, 2011·JACC. Cardiovascular Interventions·Michael C McDanielHabib Samady
Apr 4, 2015·Heart Views : the Official Journal of the Gulf Heart Association·Surender DeoraTejas M Patel
Oct 21, 2015·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·M Bilal IqbalUNKNOWN British Columbia Cardiac Registry Investigators
Jul 11, 2012·Nature Reviews. Cardiology·Javier Escaned
Feb 26, 2015·Circulation. Cardiovascular Interventions·Ron Waksman, Edward Koifman
May 15, 2020·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Robert F RileyFarouc A Jaffer
Jan 1, 2014·Heart Asia·Debabrata Dash
Jan 30, 2019·Archives of Medical Science : AMS·Rafał JanuszekStanisław Bartuś
Jul 15, 2021·The American Journal of Cardiology·Rafał WolnyAdam Witkowski
Oct 7, 2021·Nature Reviews. Cardiology·Frans J BeerkensGeorge D Dangas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Related Papers

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
Parker Grow, S Tanveer Rab
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
Gabriel MaluendaAugusto D Pichard
© 2021 Meta ULC. All rights reserved